IDSA gathered 30 diverse leaders from across the United States (and Malawi) for the launch of the inaugural IDSA Leadership Institute in early May. 

Many medical specialties have acknowledged disparities in their healthcare workforce and have made strategic changes to address diversity and inclusion as an innovation challenge for their medical societies.

Last month, over 100 fellows interested in pursuing a career in clinical practice participated in the annual IDSA Clinical Fellows Meeting. Read about what the meeting entails and how you can get involved.

The announcement of the bankruptcy of Achaogen, the small company that developed plazomicin, underscores the urgent need for the federal government to protect and strengthen the antibiotic pipeline.

The Journal of Infectious Diseases (JID) and the US Centers for Disease Control (CDC) are inviting submissions for a thematic supplement titled “Infectious Diseases and Injection Drug Use: Public Health Burden and Response.”

The House Appropriations Committee passed its FY2020 Labor, Health, and Human Services funding bill on May 8, addressing key concerns of IDSA/HIVMA members who have advocated for deeper investments in ID and HIV prevention, care and research.

IDSA members and staff attended a recent meeting of the American Medical Association’s Relative Value Scale Update Committee (RUC) to ensure that concerns of the infectious diseases community are considered as relative work values are assigned to revised CPT® codes.

IDSA was invited to deliver statements to officials from the Department of Health and Human Services and Department of State ahead of the World Health Assembly, May 20 – 28 in Geneva, Switzerland. 

The U.S. Department of Health & Human Services Office of HIV/AIDS and Infectious Disease Policy has published a Request for Information (RFI) in the Federal Register seeking written comments and recommendations for a Federal Action Plan responding to the surge of sexually transmitted infections, including strategies to improve the efficiency, effectiveness, coordination, accountability, and impact of the federal response.  

IDSA member Eugene Shapiro, MD, FIDSA has been selected to serve on the second session of Department of Health and Human Service’s (HHS) Tick-borne Disease Working Group, which resumes its activities with an in-person meeting in Washington, DC on June 4. IDSA engagement in this group is essential to promote evidence-based approaches to treating tick-borne diseases.

The administration is expected to soon release updated rules and proposed rules related to when an immigrant who is a legal U.S. resident may be considered a “public charge,” affecting their ability to enter or stay in the U.S. 

As Congress decides funding priorities for the year ahead, HIVMA Chair Dr. W. David Hardy wrote this opinion piece in The Baltimore Sun on the work, resources and policies needed to reach the administration’s stated goal of ending HIV as an epidemic.